Background. It is postulated that the surge in incidence and severity of group A streptococcus (GAS) infections since the 1980s is due to the emergence of strains of GAS with increased virulence. We used active, populationbased surveillance of invasive GAS disease, serologically confirmed pharyngitis, and carriage to determine whether particular strains were associated with invasive disease.
toxin-mediated manifestations, such as streptococcal toxic shock syndrome (STSS). A surge in the incidence and severity of GAS infections since the 1980s has been documented in many industrialized countries [1] [2] [3] [4] [5] [6] [7] [8] . These increased rates appear to have persisted well into the 1990s, and they have been largely attributed to the emergence of GAS strains with high potential for causing severe human infection. Certain studies have pointed to an association between particular M serotypes (or emm genotypes) and severe GAS infection [1, 2, [9] [10] [11] [12] . A number of studies have also suggested that serious GAS disease is associated with the emergence of highly virulent GAS clones [10, 13, 14] , whereas others have found little or no evidence of this association [15] [16] [17] [18] . The concept of M serotypes or strains with increased virulence capacity therefore remains controversial. (12) 8 (7) 16 (7) 6.1 0 0 1 (1) 1 (1) 11.0 3 (4) 0 0 3 (1) 12.0 10 (13) 3 (9) 27 (25) 40 (18) 19. NOTE. Data are no. (%) of isolates. a This sequence type was included because it was confirmed to be a GAS isolate by the rapid latex agglutination test.
The virulence of individual strains can best be determined through population-based studies, which use a representative sample of strains collected from cases of invasive disease, pharyngitis, and no disease (carriage). Carriage prevalence data are necessary to accurately evaluate the general ability of strains to cause disease. However, most studies have only included strains collected from individuals with disease or without appropriate control strains or have not collected control strains in a representative fashion. To our knowledge, there has been no study that has compared groups of strains collected during active population-based surveillance with the use of serological confirmation to distinguish pharyngitis from carriage isolates. The aim of the present study was to determine whether certain GAS emm types or clones are significantly associated with particular manifestations of disease or carriage.
MATERIALS AND METHODS
Isolate selection. Sterile-site isolates were collected during population-based prospective statewide active surveillance of invasive GAS disease in Victoria, Australia, from April 2002 to March 2003. For the purposes of the present study, cases of cellulitis, bursitis, and abscesses were categorized as soft-tissue infections; pneumonia, meningitis, septic arthritis, mastoiditis, osteomyelitis, bacteremia, septicemia, and toxic shock syndrome were classified as bacteremia/other; and cases of NF were categorized separately. For the purposes of analysis, isolates from cases of NF and soft-tissue infections were grouped together. Isolates were included if they came from persons resident in metropolitan Melbourne, defined by the metropolitan taxi boundary (representing a radius of 25-40 km around central Melbourne).
Pharyngitis isolates were collected from prospective familybased surveillance of acute pharyngitis in Melbourne from August 2001 to November 2002. This study enrolled 202 families (852 individuals) from 3 diverse geographic and socioeconomic regions of greater Melbourne. Throat swabs were collected from individuals with sore throats, and paired serum samples (acute and convalescent) were collected from persons with swabs positive for GAS to determine anti-streptolysin-O and anti-DNase B titers. Pharyngitis isolates were included only from persons with a positive GAS throat swab and serological confirmation of recent GAS infection. Further details of the methodology of the study have been described elsewhere [19, 20] .
Carriage isolates were collected during the same study. Throat swabs were collected from participants on 3 separate occasions to determine GAS carriage during spring (August 2001), summer (February 2002), and winter (July 2002). All individuals were asymptomatic and had normal throat examination findings. GAS isolates from patients with a sore throat but who did not have a serological response to infection were included in the carriage group.
All invasive and pharyngitis isolates and a random sample of carriage isolates from each period were included. The first isolate was included from individuals who had 11 episode of GAS carriage or pharyngitis of the same emm type, to minimize bias due to prolonged carriage.
Swab collection and isolate storage. All throat swabs were placed in Amies transport medium with charcoal and trans- ported in a cooler to the laboratory. Swabs were cultured on Columbia agar with 5% horse blood (Oxoid) within 24 h, to avoid loss of viability. Plates were incubated aerobically at 35ЊC for up to 48 h. All b-hemolytic colonies indicative of GAS were confirmed with a rapid latex agglutination test (Oxoid). emm gene characterization. DNA extraction and emm gene polymerase chain reaction (PCR) were performed using standard methodology [21] and primers 1 and 2 [22] . Sequence analysis was undertaken using methods described elsewhere [21] , with some modifications. Homology searches were performed using the Centers for Disease Control and Prevention's (CDC) Streptococcus Laboratory emm type database (http:// www.cdc.gov/ncidod/biotech/strep/strepindex.htm). Sequence comparisons were undertaken using the BLAST program (http: //www.ncbi.nlm.nih.gov/BLAST/). Sequences were assigned a given emm type if they showed у95% homology over the first 160 bases of sequence, allowing for small insertions and deletions (indels) of up to 7 codons that did not shift the open reading frame. The reference M serotype was denoted by ".0" (e.g., emm3.0, emm1.0, and emm12.0), to allow for the classification of subtypes. emm subtypes are so designated because they share overall nucleotide homology with the reference strain, with some minor differences (e.g., emm3.1 and emm3.2).
Random amplification of polymorphic DNA (RAPD) profiling and analysis. RAPD profiling was performed on isolates belonging to the 5 most common emm types (types 1, 4, 12, 28, and 75) using methods described elsewhere [23] , with some modifications. The H2 primer (5 -CCTCCCGCCACC-3 ) (Promega) was chosen for PCR amplification, because this was shown in previous studies in our laboratory to be the most discriminatory primer (data not shown). RAPD patterns were compared by visual examination and the use of GelCompar software (version 4.0; Applied Maths). Isolates for which genomic DNA could not be amplified or was poorly amplified were excluded from the analysis (11/158 isolates). RAPD profiles were defined by the relative positions and intensity of DNA bands lying between 300 and 2642 bp. Strains were assigned the same type if the relative positions of the bands corresponded.
Superantigen gene detection. A random selection of iso- 
lates ( ) was chosen for PCR detection of all 11 supern p 87 antigen genes-speA, speC, speG, speH, speI, speJ, speK, speL, speM, ssa, and smeZ-using methods outlined in a related study (R.C., S.R., T. Gooding, et al., unpublished data).
Data analysis. All statistical analyses were performed using SPSS (release 12.0.1; SPSS) and Epi Info (version 3.3; CDC) software. The statistical analysis plan was determined a priori. The x 2 for trend statistic was used to assess differences in proportions and to test for departures from linear trends associated with an increasing severity of clinical manifestations of GAS acquisition (assuming that carriage, pharyngitis, and invasive disease represent a linear increase in the severity of these manifestations). Two-sided was considered statistically sig-P ! .05 nificant. The risk ratio (RR) was determined to assess the strength of the association between emm type or RAPD profile and infection.
The pharyngitis and carriage isolates were grouped together for the determination of associations between invasive disease and pharyngitis or carriage (i.e., noninvasive disease). The sterile site and pharyngitis isolates were grouped together for the determination of associations between invasive disease or pharyngitis (i.e., disease states), compared with carriage. These associations were determined using the most common allele (subtype) within the most frequently occurring emm type.
RESULTS
Two hundred twenty isolates were included: 78 invasive, 34 pharyngitis, and 108 carriage. The median age of the individuals in the group from whom these isolates were collected was 41.5 (range, 0.21-96), 10.0 (range, 2-44), and 9.0 (range, 1-41) years, respectively, and the proportion of male subjects was 55%, 32%, and 54%, respectively. Thirty of 78 sterile-site isolates were from persons with bacteremia/other infections, 32 were from persons with soft-tissue infections, and 6 were from persons with NF. Clinical information was not recorded for 10 subjects.
emm type. Of the 35 distinct emm types identified, the 5 most frequently occurring overall were emm1 (24.6 %), emm12 (18.2%), emm28 (15.5%), emm4 (7.3%), and emm75 (6.8%) (table 1) . emm1, emm75, emm28, and emm4 were the most frequent types in pharyngitis isolates. emm12 and emm1 predominated in carriage isolates. emm1, emm12, and emm28 predominated in invasive isolates, but emm108 and emm94 were also among the 6 most prevalent invasive emm types.
emm1 accounted for 30% (9/30 isolates) of all bacteremia/ other infections, 83% (5/6 isolates) of all cases of NF, and 25% (8/32 isolates) of all soft-tissue infections. emm12 and emm28 accounted for 20% ( (table 2) . emm12 showed a reduced association with invasive disease or pharyngitis when both sets of emm type data were analyzed (table 2) and a corresponding significant decrease in the proportion of emm12 isolates with increasing severity of disease (table 2) . No other statistically significant associations were observed.
RAPD profile. Thirteen distinct RAPD profiles (designated A to O) were identified. RAPD profiles A, F, and L predominated overall and in each of the 3 groups of isolates. However, RAPD profile B was also prevalent in the pharyngitis isolates (table 3) . RAPD profile A predominated in emm1 strains, and profiles F and L were associated only with emm12 and emm28 isolates, respectively, but greater heterogeneity was observed in the emm4 and emm75 strains ( figure 1) .
Association between RAPD profile and isolate category. There was no association between any RAPD profile and invasive disease, compared with pharyngitis or carriage, or be- tween any RAPD profile and invasive disease or pharyngitis, compared with carriage (table 4). In particular, the associations between emm1 and disease, rather than carriage, that were evident in the subset analysis of the 5 most common emm types (table 2) were no longer significant when the isolates instead were analyzed by RAPD profile. No single RAPD profile predominated in cases of bacteremia, but RAPD profile A predominated in NF and soft-tissue infections (56.5% of all isolates) and was significantly more common in these infections than in bacteremia (RR, 2.69 [95% CI, 1.05-6.88]).
Analysis of superantigen genotyping. All emm1 isolates carried the speA, speB, speG, and smeZ genes but lacked speC, speH, speI, ssa, speK, speL, and speM genes (table 5) . speJ was isolated in 18 emm1 strains. emm12 isolates lacked the speA 
DISCUSSION
We found no clear evidence that highly virulent strains of GAS are responsible for the surge in incidence and severity of GASrelated disease; even though emm12 was the second most common emm type among invasive isolates, the population-based analysis demonstrated a predilection for carriage rather than disease. There was no association between any other emm type and any pattern of disease or carriage, although small numbers limited our ability to determine a significant association between emm1 and NF or between emm108.1 or emm94 isolates and invasive disease.
However, emm gene characterization alone does not provide any measure of the extent of genomic differentiation between strains because of high-frequency intragenic and intergenic recombinational events [24] [25] [26] . We therefore used RAPD profiling as general measure of genomic changes within unknown regions of unknown stability in the streptococcal genome. This analysis confirmed that, although single RAPD profiles predominated in emm1 and emm28 isolates, there was more diversity among emm12, emm4, and emm75 isolates. The biological significance of this association between particular RAPD types and emm types remains unknown. The apparent associations between particular GAS strains, defined by emm type, and particular forms of GAS carriage or disease disappeared when the strains were instead characterized by their RAPD profile.
We also found no association between disease type and any superantigen gene. An association between the production of streptococcal pyrogenic exotoxin A (SPEA) and STSS [12] and between speA and invasive disease has been observed previously [13] . Other studies have reported no association between superantigen genotype and STSS [27] and a similar prevalence of speA among strains from cases of invasive and noninvasive disease [28, 29] . A lack of association between SPEA and invasive disease was found in Belgium during 1993-1994, and a high proportion of invasive strains (70.8%) lacked the speA gene [18] . A recent investigation in the United States of pediatric GAS pharyngeal isolates and their relationship to strains isolated from cases of invasive disease found that a significantly higher proportion of pharyngeal isolates were positive for both speA and speC than were invasive strains [30] .
Other studies support our contention that the prevalence in invasive disease of organisms belonging to particular genetic profiles simply reflects their overall prevalence in the population. A lack of correlation between genomic type and severity of infection caused by GAS T1M1 strains was observed in isolates collected in Finland between 1988 and 1995 [31] . A retrospective study of strains collected from cases of invasive and noninvasive disease in Belgium during 1993-1994 found that no single genotype was significantly associated with severe disease [18] , even though it had been suggested that one of the dominant profiles in that study (pulsed-field gel electrophoresis [PFGE] type 01/emm1) was responsible for the increase in invasive infections since the 1980s [12, 32] . A recent comparison 0 19  0  19 19  0 19  0 19  0  0 19 19  0  1 18 19  0  19  0  19  0  0  19  3.1  0  2  0  2  2  0  2  0  2  0  0  2  1  1  2  0  0  2  2  0  2  0  2 of strains from individuals with invasive disease and uncomplicated infection in the United States found that no clone within M1 and M3 strains had a statistically increased association with invasive disease [15] , even though highly virulent M1 [13] and M3 [33] clones have been described in the United States. By contrast, a small study of 56 M1 strains from invasive and noninvasive infections in the United States in the 1980s found that a significantly lower proportion of isolates from patients with uncomplicated infection only had the dominant RFLP profile (RFLP profile I) associated with invasive cases or carried the speA gene [13] . It was postulated that a highly virulent clone had emerged that was possibly a variant of preexisting strains and that changes in herd immunity or public health practices had little effect on the observed increase in serious GAS disease. A study from Hong Kong also found that, although most M1 strains isolated from cases of invasive disease and pharyngitis produced indistinguishable PFGE patterns, M1 was still found in a significantly greater proportion of invasive isolates than in noninvasive pharyngeal and skin strains [10] . Similarly, the premise that the emergence and spread of a newly identified M1 GAS clone after 1992 in Japan was associated with an increase in invasive streptococcal infections at that time simply because this clone had a different PFGE profile from any other profile observed before 1992 [14] fails to consider how the acquisition of this clone resulted in either severe infection or uncomplicated disease in different individuals. A recent study from Denmark found an apparent association between invasive disease and emm1 strains when a populationbased collection of invasive, pharyngitis, and carriage isolates was compared [34] . However, pharyngitis and carriage isolates were collected only by passive surveillance (i.e., voluntary submission of swabs by general practitioners), and only 17 carriage isolates were included.
All of these studies were limited by the absence of appropriate control strains from asymptomatic carriers or a clear process for ensuring that invasive and pharyngitis strains were actively and comprehensively collected from the same denominator population at the same time. To our knowledge, our study is the first to include invasive, pharyngitis, and carriage isolates collected using active surveillance in the same geographic region at the same time. Moreover, we used serological criteria to distinguish pharyngitis from carriage isolates. An antibody response can be demonstrated in only ∼50% of people with GAS culture-positive sore throat, which suggests that the remainder of cases represent GAS carriage [35, 36] . Omitting serological confirmation would therefore result in the misclassification of half of all pharyngitis isolates.
The clear predominance of emm1, particularly isolates of RAPD profile A, in NF may suggest a particular association with this distinctive manifestation. We are analyzing these strains further to determine whether they have features that promote the spread of infection within connective tissue.
The predominance of emm1, emm12, and emm28 in invasive disease is consistent with recent observations from the United States and Canada [8, 37, 38] . We found only 1 emm3 allele (emm3.1) in isolates from invasive disease, which is similar to the distribution of this emm type in Argentina [39] but contrasts with that in the United States and Europe, where M3 is still one of the major invasive types [2, 3, 8, 11, 29] . We found that a relatively high proportion of invasive strains were emm108, which has not been commonly associated with invasive disease in industrialized countries. Only 1 emm108 isolate was observed in recent multistate population surveillance of invasive GAS disease in the United States [37] . The unique association between emm108 and invasive disease in the present study, as well as associated case fatalities, requires further investigation.
Our finding that the same emm types predominated in invasive and noninvasive infection indicates that the general population represents a significant proportion of the GAS reservoir in the community and harbors strains capable of causing disease. We also found that homogenous strains were associated with different disease states, which supports the role of nonbacterial factors (host and environmental) as key determinants of disease outcome, although distinct gene-expression patterns in GAS isolates from invasive and pharyngeal infections has also been shown to account for variations in virulence in strains of the same serotype [40] . Colonization may occur in individuals without M serotype-specific antibody and manifest as a benign infection or carriage. The course of infection and progress to severe infection may primarily depend on an individual's state of immunity and genetic constitution as well as on antibody levels to the numerous extracellular products secreted by GAS. Low antibody titers against M1 GAS strains have been observed in patients with bacteremia and in those who died of invasive GAS disease, which indicates a lack of immune response [5] . Similarly, it has been suggested that the absence of specific antibody to a superantigen is a prerequisite to susceptibility to STSS caused by each superantigen [41, 42] . It has also been shown that certain HLA class II haplotypes confer strong protection against systemic GAS disease, including STSS and NF, yet other haplotypes increase the risk of severe infection, which supports the role of host immunogenetics in influencing the outcome of streptococcal infections [43] . A recent study observed a lack of correlation between any of 226 genes coding for GAS virulence factors and extracellular surface proteins and either invasive or noninvasive infections, which further highlights the lack of inherent ability of GAS to cause invasive disease [44] .
Undoubtedly, underlying conditions-such as diabetes mellitus, injection drug use, immunosuppression, HIV/AIDS, and alcohol abuse-are also significant predictors of clinical disease [8] . It was recently shown that individuals with STSS were significantly more likely to have at least 1 underlying medical condition, compared with those without STSS [8] . A recent study found that the serum superantigen-neutralizing capacities of an individual's serum against their own isolate was similar for people who had invasive and noninvasive disease [34] , which suggests that the host response may be independent of the type or origin of the isolate.
We conclude that there is little evidence to support the contention that highly virulent GAS clones have emerged in metropolitan Melbourne. The exception is the association between RAPD profile A and NF. The finding that the same strains are equally associated with invasive disease, pharyngitis, and carriage implicates host and/or environmental factors as the primary determinants of the course of infection after exposure to GAS.
